National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

被引：326

作者：

Kimball, Alexa B. ^{[1
,2
,3
]}

Gladman, Dafna ^{[6
]}

Gelfand, Joel M. ^{[7
,8
]}

Gordon, Kenneth ^{[9
]}

Horn, Elizabeth J.

Korman, Neil J.

Korver, Gretchen ^{[4
]}

Krueger, Gerald G. ^{[4
]}

Strober, Bruce E. ^{[10
]}

Lebwohl, Mark G. ^{[5
,11
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Brigham & Womens Hosp, Boston, MA 02114 USA

[3] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA

[4] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA

[5] Mt Sinai Sch Med, New York, NY USA

[6] Toronto Western Hosp, Ctr Prognosis Studies, Univ Hlth Network, Toronto Western Res Inst,Psoriat Arthritis Progra, Toronto, ON M5T 2S8, Canada

[7] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA

[8] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA

[9] Evanston NW Hlthcare, Div Dermatol, Skokie, IL USA

[10] Case Western Reserve Univ Hosp, Cleveland, OH USA

[11] NYU, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2008.01.006

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

There have been several articles and reports in recent months about comorbidities and risks that affect psoriasis patients in addition to their underlying disease. This piece reviews the current literature and begins to address what should be done with this new information by updating the clinician about what health screening tests, preventative exams, and referrals should be considered in this population.

引用

页码：1031 / 1042

页数：12

共 144 条

[1] CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].

Abrams, JR ;

Lebwohl, MG ;

Guzzo, CA ;

Jegasothy, BV ;

Goldfarb, MT ;

Goffe, BS ;

Menter, A ;

Lowe, NJ ;

Krueger, G ;

Brown, MJ ;

Weiner, RS ;

Birkhofer, MJ ;

Warner, GL ;

Berry, KK ;

Linsley, PS ;

Krueger, JG ;

Ochs, HD ;

Kelley, SL ;

Kang, SW .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252

[2]

*AG HEALTHC RES QU, 2002, ACREEN DEPR REC RAT

[3] CANCER INCIDENCE IN PATIENTS WITH PSORIASIS [J].

ALDERSON, MR ;

CLARKE, JA .

BRITISH JOURNAL OF CANCER, 1983, 47 (06) :857-859

[4] Autoimmune diseases and multiple sclerosis [J].

Alemany-Rodríguez, MJ ;

Aladro, Y ;

Amela-Peris, R ;

Pérez-Viéitez, MC ;

Reyes-Yáñez, MP ;

Déniz-Naranjo, MC ;

Sánchez-García, F .

REVISTA DE NEUROLOGIA, 2005, 40 (10) :594-597

[5] Improved survival in psoriatic arthritis with calendar time [J].

Ali, Yaser ;

Tom, Brian D. M. ;

Schentag, Catherine T. ;

Farewell, Vernon T. ;

Gladman, Dafna D. .

ARTHRITIS AND RHEUMATISM, 2007, 56 (08) :2708-2714

[6]

American Heart Association, MET SYNDR

[7] Risk of cancer with cyclosporine in psoriasis [J].

Arellano, F .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 :15-17

[8] Medical history and risk for lymphoma:: results of a population-based case-control study in Germany [J].

Becker, N ;

Deeg, E ;

Rüdiger, T ;

Nieters, A .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (01) :133-142

[9] PRIMARY TOTAL KNEE ARTHROPLASTY IN PATIENTS WITH PSORIASIS [J].

BEYER, CA ;

HANSSEN, AD ;

LEWALLEN, DG ;

PITTELKOW, MR .

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1991, 73 (02) :258-259

[10] STATISTICAL ASSOCIATION BETWEEN PSORIASIS AND DIABETES - FURTHER RESULTS [J].

BINAZZI, M ;

CALANDRA, P ;

LISI, P .

ARCHIV FUR DERMATOLOGISCHE FORSCHUNG, 1975, 254 (01) :43-48

← 1 2 3 4 5 6 7 8 9 10 →